Xtl Biopharmaceuticals (XTLB) Non-Current Assets (2009 - 2024)
Xtl Biopharmaceuticals' Non-Current Assets was $7.21 million in the quarter ended Dec 31, 2024, compared with $380,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Non-Current Assets (2009 - 2024) Analysis & Trends
From the quarter ended Mar 31, 2009 onward, Xtl Biopharmaceuticals has reported Non-Current Assets for 42 quarters.
- Non-Current Assets shows a five-year compound annual growth rate of 80.0% (years ended Dec 2019 to Dec 2024).
- In earlier years, Non-Current Assets was $380,000 in the year ended Dec 31, 2023 (unchanged), $380,000 in the year ended Dec 31, 2022 (-0.3%), $381,000 in the year ended Dec 31, 2021 (-0.3%) and $382,000 in the year ended Dec 31, 2020 (unchanged).
- The figure for the quarter ended Dec 31, 2024 marks the highest quarterly Non-Current Assets in data going back to the quarter ended Mar 31, 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 7.21 Mn |
| Dec 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 380,000.00 |
| Jun 30, 2022 | 381,000.00 |
| Mar 31, 2022 | 381,000.00 |
| Dec 31, 2021 | 381,000.00 |
| Sep 30, 2021 | -382,000.00 |
| Jun 30, 2021 | 382,000.00 |
| Mar 31, 2021 | 382,000.00 |
| Dec 31, 2020 | 382,000.00 |
| Sep 30, 2020 | -381,000.00 |
| Jun 30, 2020 | 381,000.00 |
| Mar 31, 2020 | 382,000.00 |
| Dec 31, 2019 | 382,000.00 |
| Mar 31, 2019 | 382,000.00 |
| Dec 31, 2018 | 380,000.00 |
| Jun 30, 2018 | 380,000.00 |
| Mar 31, 2018 | 380,000.00 |
| Dec 31, 2017 | 380,000.00 |
| Sep 30, 2017 | 1,000.00 |
API Access
Xtl Biopharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();